Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study-Reference-Cited by-同舟云学术

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Published:2010-12 Issue:9758 Volume:376 Page:2075-2085
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cavo Michele,Tacchetti Paola,Patriarca Francesca,Petrucci Maria Teresa,Pantani Lucia,Galli Monica,Di Raimondo Francesco,Crippa Claudia,Zamagni Elena,Palumbo Antonio,Offidani Massimo,Corradini Paolo,Narni Franco,Spadano Antonio,Pescosta Norbert,Deliliers Giorgio Lambertenghi,Ledda Antonio,Cellini Claudia,Caravita Tommaso,Tosi Patrizia,Baccarani Michele

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

3. Importance of achieving a complete response in multiple myeloma, and the impact of novel agents;Chanan-Khan;J Clin Oncol,2010

4. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma;van de Velde;Haematologica,2007

5. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial;Facon;Lancet,2007

Cited by 747 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction prior to autologous haematopoietic cell transplantation in multiple myeloma;British Journal of Haematology;2024-09-09

2. Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades;Transplantation and Cellular Therapy;2024-08

3. Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study;HemaSphere;2024-07-29

4. Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: Opportunities for research among patients and caregivers;Brain, Behavior, and Immunity;2024-07

5. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-06-28